In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp

H. Prazeres, J. P. Couto, F. Rodrigues, J. Vinagre, J. Torres, V. Trovisco, T. C. Martins, M. Sobrinho-Simoes, P. Soares
  • Endocrine Related Cancer, May 2011, Bioscientifica
  • DOI: 10.1530/erc-10-0258

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Paula Soares